Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland
· Delayed Price · Currency is CHF 6.93
-0.37 (-5.07%)
Apr 24, 2025, 3:46 PM CET
Newron Pharmaceuticals Revenue
In the year 2024, Newron Pharmaceuticals had annual revenue of 51.39M EUR with 467.41% growth. Newron Pharmaceuticals had revenue of 47.98M in the half year ending December 31, 2024, with 1,370.07% growth.
Revenue
51.39M EUR
Revenue Growth
+467.41%
P/S Ratio
3.02
Revenue / Employee
2.34M EUR
Employees
22
Market Cap
145.70M CHF
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.39M | 42.33M | 467.41% |
| Dec 31, 2023 | 9.06M | 2.96M | 48.62% |
| Dec 31, 2022 | 6.09M | 332.00K | 5.76% |
| Dec 31, 2021 | 5.76M | 504.00K | 9.59% |
| Dec 31, 2020 | 5.26M | -1.78M | -25.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.40B |
| Novartis AG | 46.87B |
| Lonza Group AG | 6.57B |
| Alcon | 8.98B |
| Galderma Group AG | 4.02B |
| Straumann Holding AG | 2.50B |
| Sonova Holding AG | 3.71B |
| Sandoz Group AG | 9.41B |
Newron Pharmaceuticals News
- 22 days ago - Newron Pharmaceuticals reports FY results - Seeking Alpha